State of New Jersey Common Pension Fund D
CRNX icon

State of New Jersey Common Pension Fund D’s Crinetics Pharmaceuticals CRNX Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Sell
29,624
-952
-3% -$35.4K ﹤0.01% 1493
2026
Q1 		$1.11M Buy
30,576
+39
+0.1% +$1.74K ﹤0.01% 1393
2025
Q4 		$1.42M Sell
30,537
-41,812
-58% -$1.86M 0.01% 1379
2025
Q3 		$3.01M Buy
72,349
+9,797
+16% +$313K 0.01% 768
2025
Q2 		$1.8M Buy
62,552
+6,674
+12% +$206K 0.01% 1367
2025
Q1 		$1.87M Buy
55,878
+17,829
+47% +$666K 0.01% 1109
2024
Q4 		$1.95M Buy
38,049
+708
+2% +$39.6K 0.01% 1325
2024
Q3 		$1.91M Sell
37,341
-3,258
-8% -$168K 0.01% 1388
2024
Q2 		$1.82M Sell
40,599
-31,501
-44% -$1.45M 0.01% 1310
2024
Q1 		$3.38M Buy
+72,100
New +$2.82M 0.01% 920

Other funds holding CRNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

State of New Jersey Common Pension Fund D's CRNX Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Crinetics Pharmaceuticals (CRNX) stake by 3.1% in Q2 2026, selling an estimated $35.4K and leaving 29,624 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1493.

State of New Jersey Common Pension Fund D first reported a position in CRNX in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.38M in Q1 2024. 128 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 29,624 shares of Crinetics Pharmaceuticals worth $1.11M as of Q2 2026.
  • State of New Jersey Common Pension Fund D sold 952 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $35.4K.
  • Crinetics Pharmaceuticals made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1493 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Crinetics Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • State of New Jersey Common Pension Fund D's Crinetics Pharmaceuticals position peaked at $3.38M in Q1 2024.
  • 128 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.